InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)
Clinical trial NCT04927169 · TERMINATED
Trial details
- NCT number
- NCT04927169
- Sponsor
- Revimmune
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2021-12-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.